Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175689086> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W3175689086 abstract "Platinum-based therapy is one of the major treatment approaches in ovarian cancer. Although greater than 80% of advanced stage ovarian cancer patients initially achieve remission with platinum therapy; the majority of this cohort eventually relapse, and develop drug-resistant disease. Resistance to chemotherapeutic drugs such as cisplatin has been attributed in part to the overexpression of Focal Adhesion Kinase (FAK), which is known to promote cancer cell survival and metastasis. In recent years, there has been heightened interest in targeting focal adhesion kinase in platinum resistant cancer as a new modality in ovarian cancer treatment. In previous studies, we have reported that Phycocyanin (C-PC), a major accessory pigment in the Limnothrix sp. 37-2-1, demonstrates cytotoxicity towards multiple cancer cell lines. Therefore, in the present study we evaluated the ability of C-PC to sensitize platinum resistant OVCAR3 cells to cisplatin treatment. We also examined the response of FAK activation by phosphorylation, to treatment with cisplatin and CP-C alone, and in combination (C-PC +cisplatin). Cell viability was determined by MTT assay, and DNA fragmentation was used to confirm apoptotic cell death. The expression of phosphorylated FAK (pFAK), total FAK, pAKT, as well as the key apoptotic regulators p21, p53, Bax, and Bcl-2 in response to the treatments were determined through western blotting. The results from our study confirm that C-PC significantly enhances the cytotoxic profile of cisplatin in OVCAR-3 cells through the induction of apoptosis as confirmed by the presence of DNA fragmentation patterns in all three treatment groups. The expression of activated pFAK was also significantly reduced in the CPC and CPC + cisplatin treatment groups and this corresponded with increased p53, p21 and Bax expression, while pAkt and Bcl-2 expression was downregulated. These results confirm a novel effect of CPC on FAK phosphorylation in platinum resistant ovarian cancer, which can be further explored towards the treatment of advanced stage disease through combination strategies. Support or Funding Information This project was supported by The Royal Dames of Cancer Research Inc., Ft. Lauderdale, Florida This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal." @default.
- W3175689086 created "2021-07-05" @default.
- W3175689086 creator A5048693569 @default.
- W3175689086 creator A5050609737 @default.
- W3175689086 creator A5062905760 @default.
- W3175689086 creator A5077746905 @default.
- W3175689086 creator A5090480110 @default.
- W3175689086 date "2019-04-01" @default.
- W3175689086 modified "2023-09-27" @default.
- W3175689086 title "Phycocyanin Enhances the Cytotoxic Profile of Cisplatin in Platinum‐Resistant Ovarian Cancer Cells by Targeting Focal Adhesion Kinase" @default.
- W3175689086 doi "https://doi.org/10.1096/fasebj.2019.33.1_supplement.816.10" @default.
- W3175689086 hasPublicationYear "2019" @default.
- W3175689086 type Work @default.
- W3175689086 sameAs 3175689086 @default.
- W3175689086 citedByCount "0" @default.
- W3175689086 crossrefType "journal-article" @default.
- W3175689086 hasAuthorship W3175689086A5048693569 @default.
- W3175689086 hasAuthorship W3175689086A5050609737 @default.
- W3175689086 hasAuthorship W3175689086A5062905760 @default.
- W3175689086 hasAuthorship W3175689086A5077746905 @default.
- W3175689086 hasAuthorship W3175689086A5090480110 @default.
- W3175689086 hasConcept C121608353 @default.
- W3175689086 hasConcept C126322002 @default.
- W3175689086 hasConcept C1491633281 @default.
- W3175689086 hasConcept C151166631 @default.
- W3175689086 hasConcept C154317977 @default.
- W3175689086 hasConcept C190283241 @default.
- W3175689086 hasConcept C202751555 @default.
- W3175689086 hasConcept C2776694085 @default.
- W3175689086 hasConcept C2778239845 @default.
- W3175689086 hasConcept C2779013556 @default.
- W3175689086 hasConcept C2780427987 @default.
- W3175689086 hasConcept C2780783641 @default.
- W3175689086 hasConcept C31573885 @default.
- W3175689086 hasConcept C43759708 @default.
- W3175689086 hasConcept C502942594 @default.
- W3175689086 hasConcept C55493867 @default.
- W3175689086 hasConcept C71924100 @default.
- W3175689086 hasConcept C86803240 @default.
- W3175689086 hasConcept C96232424 @default.
- W3175689086 hasConceptScore W3175689086C121608353 @default.
- W3175689086 hasConceptScore W3175689086C126322002 @default.
- W3175689086 hasConceptScore W3175689086C1491633281 @default.
- W3175689086 hasConceptScore W3175689086C151166631 @default.
- W3175689086 hasConceptScore W3175689086C154317977 @default.
- W3175689086 hasConceptScore W3175689086C190283241 @default.
- W3175689086 hasConceptScore W3175689086C202751555 @default.
- W3175689086 hasConceptScore W3175689086C2776694085 @default.
- W3175689086 hasConceptScore W3175689086C2778239845 @default.
- W3175689086 hasConceptScore W3175689086C2779013556 @default.
- W3175689086 hasConceptScore W3175689086C2780427987 @default.
- W3175689086 hasConceptScore W3175689086C2780783641 @default.
- W3175689086 hasConceptScore W3175689086C31573885 @default.
- W3175689086 hasConceptScore W3175689086C43759708 @default.
- W3175689086 hasConceptScore W3175689086C502942594 @default.
- W3175689086 hasConceptScore W3175689086C55493867 @default.
- W3175689086 hasConceptScore W3175689086C71924100 @default.
- W3175689086 hasConceptScore W3175689086C86803240 @default.
- W3175689086 hasConceptScore W3175689086C96232424 @default.
- W3175689086 hasIssue "S1" @default.
- W3175689086 hasLocation W31756890861 @default.
- W3175689086 hasOpenAccess W3175689086 @default.
- W3175689086 hasPrimaryLocation W31756890861 @default.
- W3175689086 hasRelatedWork W2008479527 @default.
- W3175689086 hasRelatedWork W2011012124 @default.
- W3175689086 hasRelatedWork W2011396543 @default.
- W3175689086 hasRelatedWork W2030883789 @default.
- W3175689086 hasRelatedWork W2068479722 @default.
- W3175689086 hasRelatedWork W2081517760 @default.
- W3175689086 hasRelatedWork W2186559937 @default.
- W3175689086 hasRelatedWork W2367297127 @default.
- W3175689086 hasRelatedWork W2489762468 @default.
- W3175689086 hasRelatedWork W2789717442 @default.
- W3175689086 hasVolume "33" @default.
- W3175689086 isParatext "false" @default.
- W3175689086 isRetracted "false" @default.
- W3175689086 magId "3175689086" @default.
- W3175689086 workType "article" @default.